Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems

Background: According to scientific literature, some 99% of patients affected by Alzheimer’s disease (AD) suffer from behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms (NPSs). In particular, agitation is one of the most difficult disorders to treat. St...

Descripció completa

Dades bibliogràfiques

Autors principals:	Damiana Scuteri, Daniele Pierobon, Martina Pagliaro, Kengo Hamamura, Takafumi Hayashi, Loris Pignolo, Pierluigi Nicotera, Giacinto Bagetta, Maria Tiziana Corasaniti
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-09-01
Col·lecció:	Pharmaceutics
Matèries:	NanoBEO HTA clinical and market analysis essential oil of bergamot dementia BPSD
Accés en línia:	https://www.mdpi.com/1999-4923/16/10/1253
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!